Global Anterior Cruciate Ligament (ACL) and Posterior Cruciate Ligament (PCL) Reconstruction Devices Market, by Procedure Type (Anterior Cruciate Ligament (ACL) Procedure and Posterior Cruciate Ligament (PCL) Procedure), by End User (Hospitals, Orthopaedic Centres, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 10,952 million in 2022 and expected to exhibit a CAGR of 7.2% over the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.
Key players operating in market are focusing on receiving product approvals from regulatory authorities, and this is expected to drive the market growth over the forecast period.
For instance, in December 2020, Arthex, a global medical device company launched SwiveLock ACL repair kit after clearance by the U.S. Food and Drug Administration.
Moreover, in August 2021, LifeNet Health, allograft biologics showcased its comprehensive portfolio of advanced biomaterials at the 2021 American Academy of Orthopaedic Surgeons (AAOSA) annual meeting, and its featured solutions include FlexiGraft QuadLink, only pre-sutured quadriceps tendons for ACL reconstruction.
Global ACL/PCL Reconstruction Devices Market – Impact of Coronavirus (COVID-19) Pandemic
The coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19 a pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 489 million cases of coronavirus disease (COVID-19) were reported till April 3, 2022, across the globe.
The spread of covid-19 worldwide showed an impact on market, as surgical procedures were kept on hold to prevent spread of covid-19. For instance, according to the survey done by Department of orthopedics, government Dharampuri medical college, India, In 2020 outpatient orthopedic services were decreased by 75% during the pandemic in India.
Browse 53 Market Data Tables and 38 Figures spread through 154 Pages and in-depth TOC on “Anterior Cruciate Ligament (ACL)/Posterior Cruciate Ligament (PCL) Reconstruction Devices Market” - Global Forecast to 2030, by Procedure Type (Anterior Cruciate Ligament (ACL) Procedure and Posterior Cruciate Ligament (PCL) Procedure), by End User (Hospitals, Orthopaedic Centres, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in the global anterior cruciate ligament (ACL)/posterior cruciate ligament (PCL) reconstruction Devices Market, click the link below:
Key players operating in market are focusing on adoption of inorganic growth strategies such as mergers, collaborations, partnerships, and acquisitions, in order to strengthen their position in the global market. For instance in February 2022, DJO, LLC, an intelligent medical devices and service provider, renewed its partnership with Professional Football Athletic Trainers Society (PFATS). This partnership focuses on injury prevention through top of the line bracing products and drives awareness of bracings benefits at an early age.
Key Takeaways of Global ACL/PCL Reconstruction Devices Market:
- Global anterior cruciate ligament (ACL)/posterior cruciate ligament (PCL) reconstruction devices market is expected to exhibit a CAGR of 7.2% over the forecast period, owing to rising launches of products. For instance, in January 2022, Zynex, Inc., a medical device manufacturer that produces and markets electrotherapy devices for use in pain management, has added post-operative and OA (Osteoarthritis) knee braces to its line of pain and rehabilitation products. Post-operative knee braces are typically used after orthopaedic surgeries such as tendon or meniscus repairs, ACL/PCL or fixing fractures of the knee.
- Among procedure type, anterior cruciate ligament (ACL) procedure segment is expected to account for largest market share during the forecast period, owing to rising research and development and product launches. For instance, in October 2018, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a part of the national institute of health (NIH), awarded Cleveland Clinic US$ 6 million to study techniques used for anterior cruciate ligament (ACL) reconstruction.
- Key players operating in the global ACL/PCL reconstruction devices market include Miach Orthopaedics, Arthrex, Smith & Nephew, Zimmer Biomet, Conmed Linvatec, MTF, RTI Biologics, Stryker, LifeNet Health, JRF, Parcus Medical, Medtronic, Tissue Regenix, Synthasome, Artelon, MedShape, Rotation Medical, CITIEFFE S.R.L, DJO Global Inc., Johnson & Johnson Services, Inc., and Meira Corporation.
